Company page

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A is a publicly traded company in China, identified by the ticker 301211. The company has a market capitalization of approximately 683.59 million USD. Hubei Biocause focuses on the pharmaceutical sector, contributing to the healthcare industry in China.

profile301211AI content: aiUpdated May 25, 2026/company/hubei-biocause-heilen-pharmaceutical-co-ltd
Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A logo
Ticker
301211
Market cap
$683.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major